Business news for the stock market

QLUPOD AG: Qlupod voted top "Telehealth Solutions Provider 2024"!


Herisau (pta047/27.05.2024/19:22 UTC+2)

Published on 27. May 2024 by QluPod AG

Herisau, Switzerland QluPod AG (

QluPod receives the next award and is voted "Top Telehealth Solutions Provider 2024"!

Following the great success of the QluPod app at the Future Innovation Summit in Dubai and the award for best telemedicine app 2023, the health monitor QluPod has received its next award: The renowned online and print magazine Healthcare Tech Outlook has voted QluPod "Top Telehealth Solutions Provider 2024". The trade magazine, which has a strong presence in the USA in particular, but also in Europe, explains that numerous subscribers have recognised the success of the Swiss health tech start-up QluPod in the further development of telemedicine. As a result, there were numerous nominations from readers, as well as from industry experts, healthcare industry executives and the editorial team of Healthcare Tech Outlook.

"The award underlines QluPod's outstanding positioning in the field of telemedicine, which is set to develop rapidly thanks to the health monitor and the proprietary QluPod app," says Aidan Burley, Head of Sales, emphasising the significance of this honour. "The award is the result of our innovative strategy and continuous technological development," adds Aidan Burley. This development is also reflected in the tireless commitment of the entire QluPod team to revolutionise telemedicine and take it to a new level.

Innovative solutions for telemedicine

A central component of Qlupod AG's mission is remote monitoring, i.e. the remote monitoring of patients. The QluPod health monitor enables regular measurement of the six most important health values: Heart rate, blood oxygen, blood sugar*, blood pressure, ECG and body temperature. The values are measured in real time and can be transmitted directly to the attending physician. This is where the QluPod revolution comes in: Not only can patients use the health monitor from anywhere, but doctors can also receive and analyse the values in their practice, clinic or even at home.

Working from home as a doctor? With the QluPod app, this vision can become a reality. The innovative technology helps doctors and nursing staff to monitor patients remotely, treat them efficiently and quickly initiate the appropriate measures if necessary. This allows doctors to work flexibly and saves patients a trip to the doctor's surgery and a long stay in the waiting room. These savings are particularly valuable in times of an overburdened healthcare system. However, remote monitoring also significantly improves the treatment of the population in remote areas.

Strategy and vision

"The Top Telehealth Solutions Provider 2024 award confirms that we are on the right path to shaping the future of telemedicine," emphasises Nikola Trajanov, Interim CEO of Qlupod AG. "We are proud to make a significant contribution to improving healthcare around the world with our technology and our vision and to make the medical profession more attractive again. The work-life balance of doctors is improving. Overtime is no longer a compulsion, but a voluntary decision."

Qlupod's strategic direction is based on the three pillars of innovation, technology and user-friendliness. By integrating new devices, continuously developing the health monitor and the QluPod app, we ensure that our products always meet the highest standards and fulfil the needs of our users. The Pro version of the app is expected to be launched in late summer 2024, a very important milestone for Qlupod AG. This will sustainably improve medical care for users and enable telemedicine to establish itself as an integral part of the healthcare system.

About QluPod:

QluPod AG is a start-up company in the field of telemedicine and develops innovative solutions to make patient care efficient and cost-effective. With the QluPod device and the associated software, the company is endeavouring to shape the future of healthcare. The offering is aimed at hospitals, care facilities, medical professionals and private individuals who want to monitor their health independently.

For more information about QluPod AG and our products, please visit our website at


This publication constitutes neither an offer to sell nor a solicitation to buy securities. Insofar as this document contains forward-looking statements, these do not represent facts and are characterised by the words "expect", "believe", "estimate", "intend", "aim", "assume" and similar expressions. These statements express the intentions, opinions or current expectations and assumptions of QluPod AG and are based on current plans, estimates and forecasts which QluPod AG has made to the best of its knowledge, but do not claim to be correct in the future. Forward-looking statements are subject to risks and uncertainties that are generally difficult to predict and are usually beyond the control of QluPod AG. It
should be noted that actual events or developments may differ materially from the events and developments expressed or implied by such forward-looking statements.


Emitter: QLUPOD AG
Bahnhofstrasse 23
9100 Herisau
Contact Person: Investor Relations
Phone: +41 71 510 05 45
ISIN(s): CH1222316429 (Share)
Stock Exchange(s): -
Other Stock Exchanges: Regelmaessige Kursfeststellung Schweiz